Keefe, Bruyette & Woods Maintains Market Perform on CME Gr, Raises Price Target to $213
Portfolio Pulse from Benzinga Newsdesk
Keefe, Bruyette & Woods analyst Kyle Voigt maintains a Market Perform rating on CME Group (NASDAQ:CME) and raises the price target from $212 to $213.
July 25, 2024 | 1:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Keefe, Bruyette & Woods analyst Kyle Voigt maintains a Market Perform rating on CME Group and raises the price target from $212 to $213.
The raised price target, although marginal, indicates a positive outlook from the analyst. This could lead to a slight positive impact on CME's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100